OLD Media Moves

Four-fifths of network stories on drugs exclude industry view

March 19, 2007

Posted by Chris Roush

Four-fifths of stories on CBS, ABC and NBC about drugs fail to include the viewpoint of the pharmaceutical industry, according to a report from the Business & Media Institute.

Drug companiesThe Institute looked at 132 stories on prescription or over-the-counter drugs from the ABC, CBS, and NBC evening newscasts between Jan. 1 and Sept. 30, 2006. Among the findings:

Industry Ignored: While covering everything from medical ‘controversies’ to breakthroughs, nearly 80 percent of the stories excluded the viewpoint of the pharmaceutical industry, failing to include either a company statement or a company spokesman.

Media Overemphasize Cost to Consumer: The broadcast networks mentioned costs to consumers or drug company revenues 11 times more often than they mentioned drug development costs.

Networks Leave Companies Unnoticed: Only 22 percent of the stories even named the company that developed the drug or drugs featured in the story.

What Development Costs?: A mere 2 percent of stories dealt with the cost of developing drugs, and even those costs were downplayed by industry skeptics.

Special Treatment for Left-Wing Causes: Nineteen stories focused on drugs that were popular liberal causes such as the morning-after pill or HPV vaccine Gardasil. The networks didn’t apply the same scrutiny to those drugs and their makers as they did to others.

Read more here.

Subscribe to TBN

Receive updates about new stories in the industry daily or weekly.

Subscribe to TBN

Receive updates about new stories in the industry.